Recently, Schipke and colleagues proposed the combined measurement of six different blood markers, BDNF, IGF-1, VEGF, TGF-beta 1, MCP-1 and IL-18 to identify Alzheimer’s disease patients [31]. Here, TGFB1 is linked to early-onset autosomal dominant Alzheimer disease.